The serum FcεRIα in SLE patients is significantly higher than that in the control group and anti‐IgE is significantly lower than that in the control group, which provides a new reference basis for the understanding and further discussion of the inflammatory mechanism of the disease. This evidence concerns the gene FCER1A and systemic lupus erythematosus.